Why Biotech Will Have a $3 Trillion Impact
Technology is unique in that it can, for lack of a better term, cheat.
Tech can use discoveries from another field to push itself forward.
A great example is the automotive industry. It took the idea of lithium-ion batteries from small smart devices and applied it to electric vehicles (EVs). That boosted the entire EV movement exponentially.
The same thing is happening right now in biotech.
Thanks to gene editing becoming cheaper, a new type of biotech is emerging. It’s going to change everything from how we grow food to how we manufacture pharmaceuticals.
It’s a small market right now, but that won’t last long. In the long term, I expect this sector to have a $3 trillion impact on our economy.
This opportunity could be as big as the EV market was 10 years ago or internet stocks 25 years ago.
I go into all the details in this week’s video.
Check it out:
(If you’d prefer to read a transcript, click here.)
Beyond Biotech: Catch Up on Our Latest Content!
Missed Winning Investor Daily this week? Click here to catch up on our latest articles!
In one video, Amber Lancaster dives into a small $6 tech stock that is set to soar as much as 4,800%. Click here to watch!
Also, be sure to check out my article from Wednesday: “Why You Should’ve Invested $1 in Crypto in 2013.” I take a look at why the bitcoin wave is over for now, but how you could soon profit on the next generation of cryptos.
That’s all for now!
Regards,
Editor, Strategic Fortunes
My career on Wall Street started while I was in college. I spent a summer interning for Merrill Lynch in the middle of the ‘90s bull market. I was fascinated with trading, and as a result, after college, I joined Salomon Brothers in the famed mortgage bond trading department. Later, I spent time at Citigroup working with credit derivatives. Eventually, I needed to walk away from the excess of Wall Street. That’s when I joined Banyan Hill in 2017. Now I help readers get ahead of the market and build their retirements.
